Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hempia is a South Korean biotechnology company specializing in the industrial and medicinal application of hemp. Established in 1998, the company focuses on the extraction and refinement of hemp-derived compounds for use in functional foods, cosmetics, and textiles. Hempia utilizes proprietary processing technologies to produce high-purity hemp seed oil and proteins, while also conducting research into the therapeutic potential of cannabinoids. The company operates a vertically integrated business model, encompassing cultivation, R&D, and manufacturing, and is a key participant in the Andong Hemp Regulation-Free Special Zone. Its products are marketed under its own brands and provided as raw materials to international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hempia.